nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Nucleic Acid Synthesis Inhibitors—Azathioprine—multiple sclerosis	0.38	1	CiPCiCtD
Azacitidine—Cladribine—multiple sclerosis	0.342	1	CrCtD
Azacitidine—Pentostatin—Cladribine—multiple sclerosis	0.0338	0.151	CrCrCtD
Azacitidine—Clofarabine—Cladribine—multiple sclerosis	0.0269	0.12	CrCrCtD
Azacitidine—Regadenoson—Cladribine—multiple sclerosis	0.0269	0.12	CrCrCtD
Azacitidine—Fludarabine—Cladribine—multiple sclerosis	0.0252	0.113	CrCrCtD
Azacitidine—Nelarabine—Cladribine—multiple sclerosis	0.0238	0.106	CrCrCtD
Azacitidine—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0238	0.106	CrCrCtD
Azacitidine—Vidarabine—Cladribine—multiple sclerosis	0.0213	0.0956	CrCrCtD
Azacitidine—Adenosine—Cladribine—multiple sclerosis	0.0213	0.0956	CrCrCtD
Azacitidine—Decitabine—Cladribine—multiple sclerosis	0.0203	0.0911	CrCrCtD
Azacitidine—DNMT3A—peripheral nervous system—multiple sclerosis	0.00341	0.381	CbGeAlD
Azacitidine—S-Adenosylmethionine—SRM—multiple sclerosis	0.000668	0.321	CrCbGaD
Azacitidine—DNMT1—retina—multiple sclerosis	0.000665	0.0744	CbGeAlD
Azacitidine—DNMT3A—nervous system—multiple sclerosis	0.000598	0.0668	CbGeAlD
Azacitidine—DNMT3A—central nervous system—multiple sclerosis	0.000575	0.0644	CbGeAlD
Azacitidine—DNMT3A—cerebellum—multiple sclerosis	0.000562	0.0629	CbGeAlD
Azacitidine—DNMT1—medulla oblongata—multiple sclerosis	0.000481	0.0538	CbGeAlD
Azacitidine—DNMT3A—brain—multiple sclerosis	0.000457	0.0511	CbGeAlD
Azacitidine—DNMT1—midbrain—multiple sclerosis	0.00044	0.0492	CbGeAlD
Azacitidine—DNMT1—spinal cord—multiple sclerosis	0.000429	0.048	CbGeAlD
Azacitidine—DNMT1—nervous system—multiple sclerosis	0.000361	0.0404	CbGeAlD
Azacitidine—DNMT1—central nervous system—multiple sclerosis	0.000348	0.0389	CbGeAlD
Azacitidine—DNMT1—cerebellum—multiple sclerosis	0.00034	0.038	CbGeAlD
Azacitidine—Clofarabine—RRM1—multiple sclerosis	0.000286	0.137	CrCbGaD
Azacitidine—Fludarabine—RRM1—multiple sclerosis	0.000277	0.133	CrCbGaD
Azacitidine—DNMT1—brain—multiple sclerosis	0.000276	0.0309	CbGeAlD
Azacitidine—Gemcitabine—RRM1—multiple sclerosis	0.000262	0.126	CrCbGaD
Azacitidine—Glucosamine—IFNG—multiple sclerosis	0.000207	0.0995	CrCbGaD
Azacitidine—Cladribine—RRM1—multiple sclerosis	0.000164	0.0789	CrCbGaD
Azacitidine—Glucosamine—MMP9—multiple sclerosis	0.000132	0.0634	CrCbGaD
Azacitidine—DNMT3A—Amcinonide—Betamethasone—multiple sclerosis	0.000116	0.0798	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Dexamethasone—multiple sclerosis	0.000116	0.0798	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Triamcinolone—multiple sclerosis	0.000113	0.078	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Prednisone—multiple sclerosis	0.000107	0.074	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Prednisolone—multiple sclerosis	0.000105	0.0723	CbGdCrCtD
Azacitidine—CDA—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000101	0.187	CbGpPWpGaD
Azacitidine—Glucosamine—TNF—multiple sclerosis	8.67e-05	0.0417	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—ZFP36L1—multiple sclerosis	7.06e-05	0.131	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—RRM1—multiple sclerosis	5.09e-05	0.0941	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—SLC11A1—multiple sclerosis	4.73e-05	0.0876	CbGpPWpGaD
Azacitidine—DNMT1—Budesonide—Methylprednisolone—multiple sclerosis	4.64e-05	0.0321	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Betamethasone—multiple sclerosis	4.57e-05	0.0316	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Dexamethasone—multiple sclerosis	4.57e-05	0.0316	CbGdCrCtD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—IRF8—multiple sclerosis	4.49e-05	0.083	CbGpPWpGaD
Azacitidine—DNMT1—Budesonide—Triamcinolone—multiple sclerosis	4.46e-05	0.0308	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Prednisone—multiple sclerosis	4.24e-05	0.0293	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Prednisolone—multiple sclerosis	4.13e-05	0.0286	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Methylprednisolone—multiple sclerosis	3.75e-05	0.0259	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Methylprednisolone—multiple sclerosis	3.75e-05	0.0259	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Betamethasone—multiple sclerosis	3.69e-05	0.0255	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Dexamethasone—multiple sclerosis	3.69e-05	0.0255	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Triamcinolone—multiple sclerosis	3.6e-05	0.0249	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Triamcinolone—multiple sclerosis	3.6e-05	0.0249	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Prednisone—multiple sclerosis	3.42e-05	0.0236	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Prednisone—multiple sclerosis	3.42e-05	0.0236	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Prednisolone—multiple sclerosis	3.34e-05	0.0231	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Prednisolone—multiple sclerosis	3.34e-05	0.0231	CbGdCrCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	3.28e-05	0.0608	CbGpPWpGaD
Azacitidine—Syncope—Dexamethasone—multiple sclerosis	2.93e-05	0.00069	CcSEcCtD
Azacitidine—Infection—Triamcinolone—multiple sclerosis	2.92e-05	0.000688	CcSEcCtD
Azacitidine—Infection—Methylprednisolone—multiple sclerosis	2.91e-05	0.000686	CcSEcCtD
Azacitidine—Haematuria—Methotrexate—multiple sclerosis	2.9e-05	0.000683	CcSEcCtD
Azacitidine—Shock—Triamcinolone—multiple sclerosis	2.89e-05	0.000681	CcSEcCtD
Azacitidine—Insomnia—Prednisolone—multiple sclerosis	2.89e-05	0.000681	CcSEcCtD
Azacitidine—Alopecia—Prednisone—multiple sclerosis	2.89e-05	0.00068	CcSEcCtD
Azacitidine—Shock—Methylprednisolone—multiple sclerosis	2.89e-05	0.00068	CcSEcCtD
Azacitidine—Hepatobiliary disease—Methotrexate—multiple sclerosis	2.88e-05	0.000678	CcSEcCtD
Azacitidine—Nervous system disorder—Methylprednisolone—multiple sclerosis	2.88e-05	0.000677	CcSEcCtD
Azacitidine—Loss of consciousness—Betamethasone—multiple sclerosis	2.87e-05	0.000676	CcSEcCtD
Azacitidine—Loss of consciousness—Dexamethasone—multiple sclerosis	2.87e-05	0.000676	CcSEcCtD
Azacitidine—Epistaxis—Methotrexate—multiple sclerosis	2.87e-05	0.000676	CcSEcCtD
Azacitidine—Hypersensitivity—Mitoxantrone—multiple sclerosis	2.87e-05	0.000676	CcSEcCtD
Azacitidine—Tachycardia—Triamcinolone—multiple sclerosis	2.87e-05	0.000676	CcSEcCtD
Azacitidine—Mental disorder—Prednisone—multiple sclerosis	2.86e-05	0.000675	CcSEcCtD
Azacitidine—Nausea—Azathioprine—multiple sclerosis	2.86e-05	0.000674	CcSEcCtD
Azacitidine—Tachycardia—Methylprednisolone—multiple sclerosis	2.86e-05	0.000674	CcSEcCtD
Azacitidine—Skin disorder—Methylprednisolone—multiple sclerosis	2.85e-05	0.000671	CcSEcCtD
Azacitidine—Erythema—Prednisone—multiple sclerosis	2.85e-05	0.00067	CcSEcCtD
Azacitidine—Malnutrition—Prednisone—multiple sclerosis	2.85e-05	0.00067	CcSEcCtD
Azacitidine—Hyperhidrosis—Triamcinolone—multiple sclerosis	2.84e-05	0.000669	CcSEcCtD
Azacitidine—Agranulocytosis—Methotrexate—multiple sclerosis	2.84e-05	0.000669	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Methylprednisolone—multiple sclerosis	2.84e-05	0.0196	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Methylprednisolone—multiple sclerosis	2.84e-05	0.0196	CbGdCrCtD
Azacitidine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	2.84e-05	0.000668	CcSEcCtD
Azacitidine—Convulsion—Betamethasone—multiple sclerosis	2.83e-05	0.000667	CcSEcCtD
Azacitidine—Convulsion—Dexamethasone—multiple sclerosis	2.83e-05	0.000667	CcSEcCtD
Azacitidine—Hypertension—Dexamethasone—multiple sclerosis	2.82e-05	0.000665	CcSEcCtD
Azacitidine—Hypertension—Betamethasone—multiple sclerosis	2.82e-05	0.000665	CcSEcCtD
Azacitidine—Asthenia—Mitoxantrone—multiple sclerosis	2.8e-05	0.000658	CcSEcCtD
Azacitidine—DNMT1—Dexamethasone—Betamethasone—multiple sclerosis	2.79e-05	0.0193	CbGdCrCtD
Azacitidine—DNMT1—Betamethasone—Dexamethasone—multiple sclerosis	2.79e-05	0.0193	CbGdCrCtD
Azacitidine—Myalgia—Dexamethasone—multiple sclerosis	2.78e-05	0.000655	CcSEcCtD
Azacitidine—Myalgia—Betamethasone—multiple sclerosis	2.78e-05	0.000655	CcSEcCtD
Azacitidine—Anxiety—Dexamethasone—multiple sclerosis	2.77e-05	0.000653	CcSEcCtD
Azacitidine—Anxiety—Betamethasone—multiple sclerosis	2.77e-05	0.000653	CcSEcCtD
Azacitidine—Discomfort—Betamethasone—multiple sclerosis	2.75e-05	0.000647	CcSEcCtD
Azacitidine—Discomfort—Dexamethasone—multiple sclerosis	2.75e-05	0.000647	CcSEcCtD
Azacitidine—Haemoglobin—Methotrexate—multiple sclerosis	2.75e-05	0.000647	CcSEcCtD
Azacitidine—Hypotension—Methylprednisolone—multiple sclerosis	2.74e-05	0.000645	CcSEcCtD
Azacitidine—Pain—Prednisolone—multiple sclerosis	2.73e-05	0.000644	CcSEcCtD
Azacitidine—Haemorrhage—Methotrexate—multiple sclerosis	2.73e-05	0.000644	CcSEcCtD
Azacitidine—DNMT1—Dexamethasone—Triamcinolone—multiple sclerosis	2.73e-05	0.0189	CbGdCrCtD
Azacitidine—DNMT1—Betamethasone—Triamcinolone—multiple sclerosis	2.73e-05	0.0189	CbGdCrCtD
Azacitidine—Pharyngitis—Methotrexate—multiple sclerosis	2.71e-05	0.000639	CcSEcCtD
Azacitidine—Urinary tract disorder—Methotrexate—multiple sclerosis	2.7e-05	0.000635	CcSEcCtD
Azacitidine—Urethral disorder—Methotrexate—multiple sclerosis	2.68e-05	0.000631	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	2.68e-05	0.000631	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	2.67e-05	0.000629	CcSEcCtD
Azacitidine—Anaphylactic shock—Dexamethasone—multiple sclerosis	2.67e-05	0.000628	CcSEcCtD
Azacitidine—Anaphylactic shock—Betamethasone—multiple sclerosis	2.67e-05	0.000628	CcSEcCtD
Azacitidine—Oedema—Betamethasone—multiple sclerosis	2.67e-05	0.000628	CcSEcCtD
Azacitidine—Oedema—Dexamethasone—multiple sclerosis	2.67e-05	0.000628	CcSEcCtD
Azacitidine—Diarrhoea—Mitoxantrone—multiple sclerosis	2.67e-05	0.000628	CcSEcCtD
Azacitidine—Insomnia—Triamcinolone—multiple sclerosis	2.66e-05	0.000626	CcSEcCtD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCL5—multiple sclerosis	2.65e-05	0.0491	CbGpPWpGaD
Azacitidine—Insomnia—Methylprednisolone—multiple sclerosis	2.65e-05	0.000625	CcSEcCtD
Azacitidine—Infection—Dexamethasone—multiple sclerosis	2.65e-05	0.000624	CcSEcCtD
Azacitidine—Infection—Betamethasone—multiple sclerosis	2.65e-05	0.000624	CcSEcCtD
Azacitidine—Ill-defined disorder—Prednisone—multiple sclerosis	2.64e-05	0.000622	CcSEcCtD
Azacitidine—Feeling abnormal—Prednisolone—multiple sclerosis	2.63e-05	0.00062	CcSEcCtD
Azacitidine—Anaemia—Prednisone—multiple sclerosis	2.63e-05	0.00062	CcSEcCtD
Azacitidine—Shock—Dexamethasone—multiple sclerosis	2.62e-05	0.000618	CcSEcCtD
Azacitidine—Shock—Betamethasone—multiple sclerosis	2.62e-05	0.000618	CcSEcCtD
Azacitidine—Dyspnoea—Triamcinolone—multiple sclerosis	2.62e-05	0.000617	CcSEcCtD
Azacitidine—Nervous system disorder—Betamethasone—multiple sclerosis	2.62e-05	0.000616	CcSEcCtD
Azacitidine—Nervous system disorder—Dexamethasone—multiple sclerosis	2.62e-05	0.000616	CcSEcCtD
Azacitidine—Thrombocytopenia—Dexamethasone—multiple sclerosis	2.61e-05	0.000615	CcSEcCtD
Azacitidine—Thrombocytopenia—Betamethasone—multiple sclerosis	2.61e-05	0.000615	CcSEcCtD
Azacitidine—Tachycardia—Betamethasone—multiple sclerosis	2.6e-05	0.000613	CcSEcCtD
Azacitidine—Tachycardia—Dexamethasone—multiple sclerosis	2.6e-05	0.000613	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Prednisone—multiple sclerosis	2.59e-05	0.0179	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Prednisone—multiple sclerosis	2.59e-05	0.0179	CbGdCrCtD
Azacitidine—Dyspepsia—Triamcinolone—multiple sclerosis	2.59e-05	0.000609	CcSEcCtD
Azacitidine—Dyspepsia—Methylprednisolone—multiple sclerosis	2.58e-05	0.000608	CcSEcCtD
Azacitidine—Hyperhidrosis—Dexamethasone—multiple sclerosis	2.58e-05	0.000607	CcSEcCtD
Azacitidine—Hyperhidrosis—Betamethasone—multiple sclerosis	2.58e-05	0.000607	CcSEcCtD
Azacitidine—Malaise—Prednisone—multiple sclerosis	2.57e-05	0.000604	CcSEcCtD
Azacitidine—Eye disorder—Methotrexate—multiple sclerosis	2.55e-05	0.000601	CcSEcCtD
Azacitidine—Syncope—Prednisone—multiple sclerosis	2.55e-05	0.000601	CcSEcCtD
Azacitidine—Anorexia—Dexamethasone—multiple sclerosis	2.54e-05	0.000599	CcSEcCtD
Azacitidine—Anorexia—Betamethasone—multiple sclerosis	2.54e-05	0.000599	CcSEcCtD
Azacitidine—Urticaria—Prednisolone—multiple sclerosis	2.54e-05	0.000598	CcSEcCtD
Azacitidine—Cardiac disorder—Methotrexate—multiple sclerosis	2.54e-05	0.000597	CcSEcCtD
Azacitidine—Fatigue—Triamcinolone—multiple sclerosis	2.53e-05	0.000597	CcSEcCtD
Azacitidine—Fatigue—Methylprednisolone—multiple sclerosis	2.53e-05	0.000596	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Prednisolone—multiple sclerosis	2.53e-05	0.0175	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Prednisolone—multiple sclerosis	2.53e-05	0.0175	CbGdCrCtD
Azacitidine—Pain—Triamcinolone—multiple sclerosis	2.51e-05	0.000592	CcSEcCtD
Azacitidine—Loss of consciousness—Prednisone—multiple sclerosis	2.5e-05	0.000589	CcSEcCtD
Azacitidine—Hypotension—Betamethasone—multiple sclerosis	2.49e-05	0.000587	CcSEcCtD
Azacitidine—Hypotension—Dexamethasone—multiple sclerosis	2.49e-05	0.000587	CcSEcCtD
Azacitidine—Angiopathy—Methotrexate—multiple sclerosis	2.48e-05	0.000584	CcSEcCtD
Azacitidine—Vomiting—Mitoxantrone—multiple sclerosis	2.48e-05	0.000583	CcSEcCtD
Azacitidine—Immune system disorder—Methotrexate—multiple sclerosis	2.47e-05	0.000581	CcSEcCtD
Azacitidine—Convulsion—Prednisone—multiple sclerosis	2.47e-05	0.000581	CcSEcCtD
Azacitidine—Mediastinal disorder—Methotrexate—multiple sclerosis	2.46e-05	0.00058	CcSEcCtD
Azacitidine—Hypertension—Prednisone—multiple sclerosis	2.46e-05	0.000579	CcSEcCtD
Azacitidine—Rash—Mitoxantrone—multiple sclerosis	2.46e-05	0.000579	CcSEcCtD
Azacitidine—Dermatitis—Mitoxantrone—multiple sclerosis	2.45e-05	0.000578	CcSEcCtD
Azacitidine—Chills—Methotrexate—multiple sclerosis	2.45e-05	0.000577	CcSEcCtD
Azacitidine—Headache—Mitoxantrone—multiple sclerosis	2.44e-05	0.000575	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	2.43e-05	0.000572	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	2.43e-05	0.000572	CcSEcCtD
Azacitidine—Arthralgia—Prednisone—multiple sclerosis	2.42e-05	0.000571	CcSEcCtD
Azacitidine—Myalgia—Prednisone—multiple sclerosis	2.42e-05	0.000571	CcSEcCtD
Azacitidine—Feeling abnormal—Triamcinolone—multiple sclerosis	2.42e-05	0.00057	CcSEcCtD
Azacitidine—Feeling abnormal—Methylprednisolone—multiple sclerosis	2.42e-05	0.000569	CcSEcCtD
Azacitidine—Anxiety—Prednisone—multiple sclerosis	2.41e-05	0.000569	CcSEcCtD
Azacitidine—Alopecia—Methotrexate—multiple sclerosis	2.41e-05	0.000569	CcSEcCtD
Azacitidine—Insomnia—Dexamethasone—multiple sclerosis	2.41e-05	0.000568	CcSEcCtD
Azacitidine—Insomnia—Betamethasone—multiple sclerosis	2.41e-05	0.000568	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	2.41e-05	0.000567	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	2.4e-05	0.000565	CcSEcCtD
Azacitidine—Discomfort—Prednisone—multiple sclerosis	2.39e-05	0.000564	CcSEcCtD
Azacitidine—Mental disorder—Methotrexate—multiple sclerosis	2.39e-05	0.000564	CcSEcCtD
Azacitidine—Malnutrition—Methotrexate—multiple sclerosis	2.38e-05	0.00056	CcSEcCtD
Azacitidine—Erythema—Methotrexate—multiple sclerosis	2.38e-05	0.00056	CcSEcCtD
Azacitidine—Hypersensitivity—Prednisolone—multiple sclerosis	2.36e-05	0.000555	CcSEcCtD
Azacitidine—Dyspepsia—Betamethasone—multiple sclerosis	2.35e-05	0.000553	CcSEcCtD
Azacitidine—Dyspepsia—Dexamethasone—multiple sclerosis	2.35e-05	0.000553	CcSEcCtD
Azacitidine—Urticaria—Triamcinolone—multiple sclerosis	2.34e-05	0.00055	CcSEcCtD
Azacitidine—Urticaria—Methylprednisolone—multiple sclerosis	2.33e-05	0.000549	CcSEcCtD
Azacitidine—Body temperature increased—Triamcinolone—multiple sclerosis	2.32e-05	0.000547	CcSEcCtD
Azacitidine—Oedema—Prednisone—multiple sclerosis	2.32e-05	0.000547	CcSEcCtD
Azacitidine—Anaphylactic shock—Prednisone—multiple sclerosis	2.32e-05	0.000547	CcSEcCtD
Azacitidine—Abdominal pain—Methylprednisolone—multiple sclerosis	2.32e-05	0.000546	CcSEcCtD
Azacitidine—Decreased appetite—Betamethasone—multiple sclerosis	2.32e-05	0.000546	CcSEcCtD
Azacitidine—Decreased appetite—Dexamethasone—multiple sclerosis	2.32e-05	0.000546	CcSEcCtD
Azacitidine—Nausea—Mitoxantrone—multiple sclerosis	2.31e-05	0.000545	CcSEcCtD
Azacitidine—Infection—Prednisone—multiple sclerosis	2.31e-05	0.000543	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	2.3e-05	0.000542	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	2.3e-05	0.000542	CcSEcCtD
Azacitidine—Back pain—Methotrexate—multiple sclerosis	2.3e-05	0.000542	CcSEcCtD
Azacitidine—Fatigue—Betamethasone—multiple sclerosis	2.3e-05	0.000542	CcSEcCtD
Azacitidine—Fatigue—Dexamethasone—multiple sclerosis	2.3e-05	0.000542	CcSEcCtD
Azacitidine—Shock—Prednisone—multiple sclerosis	2.29e-05	0.000538	CcSEcCtD
Azacitidine—Pain—Betamethasone—multiple sclerosis	2.28e-05	0.000537	CcSEcCtD
Azacitidine—Pain—Dexamethasone—multiple sclerosis	2.28e-05	0.000537	CcSEcCtD
Azacitidine—Nervous system disorder—Prednisone—multiple sclerosis	2.28e-05	0.000536	CcSEcCtD
Azacitidine—Tachycardia—Prednisone—multiple sclerosis	2.27e-05	0.000534	CcSEcCtD
Azacitidine—Skin disorder—Prednisone—multiple sclerosis	2.26e-05	0.000531	CcSEcCtD
Azacitidine—Hyperhidrosis—Prednisone—multiple sclerosis	2.25e-05	0.000529	CcSEcCtD
Azacitidine—Anorexia—Prednisone—multiple sclerosis	2.21e-05	0.000521	CcSEcCtD
Azacitidine—Ill-defined disorder—Methotrexate—multiple sclerosis	2.21e-05	0.00052	CcSEcCtD
Azacitidine—Anaemia—Methotrexate—multiple sclerosis	2.2e-05	0.000518	CcSEcCtD
Azacitidine—Feeling abnormal—Betamethasone—multiple sclerosis	2.2e-05	0.000518	CcSEcCtD
Azacitidine—Feeling abnormal—Dexamethasone—multiple sclerosis	2.2e-05	0.000518	CcSEcCtD
Azacitidine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	2.18e-05	0.000514	CcSEcCtD
Azacitidine—Gastrointestinal pain—Betamethasone—multiple sclerosis	2.18e-05	0.000514	CcSEcCtD
Azacitidine—Hypersensitivity—Triamcinolone—multiple sclerosis	2.17e-05	0.00051	CcSEcCtD
Azacitidine—Hypersensitivity—Methylprednisolone—multiple sclerosis	2.16e-05	0.000509	CcSEcCtD
Azacitidine—Malaise—Methotrexate—multiple sclerosis	2.15e-05	0.000505	CcSEcCtD
Azacitidine—Leukopenia—Methotrexate—multiple sclerosis	2.13e-05	0.000501	CcSEcCtD
Azacitidine—Urticaria—Betamethasone—multiple sclerosis	2.12e-05	0.000499	CcSEcCtD
Azacitidine—Urticaria—Dexamethasone—multiple sclerosis	2.12e-05	0.000499	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	2.12e-05	0.000498	CcSEcCtD
Azacitidine—Dizziness—Prednisolone—multiple sclerosis	2.11e-05	0.000498	CcSEcCtD
Azacitidine—Asthenia—Triamcinolone—multiple sclerosis	2.11e-05	0.000497	CcSEcCtD
Azacitidine—Body temperature increased—Betamethasone—multiple sclerosis	2.11e-05	0.000497	CcSEcCtD
Azacitidine—Abdominal pain—Betamethasone—multiple sclerosis	2.11e-05	0.000497	CcSEcCtD
Azacitidine—Body temperature increased—Dexamethasone—multiple sclerosis	2.11e-05	0.000497	CcSEcCtD
Azacitidine—Abdominal pain—Dexamethasone—multiple sclerosis	2.11e-05	0.000497	CcSEcCtD
Azacitidine—Asthenia—Methylprednisolone—multiple sclerosis	2.1e-05	0.000496	CcSEcCtD
Azacitidine—Insomnia—Prednisone—multiple sclerosis	2.1e-05	0.000495	CcSEcCtD
Azacitidine—Pruritus—Triamcinolone—multiple sclerosis	2.08e-05	0.00049	CcSEcCtD
Azacitidine—Cough—Methotrexate—multiple sclerosis	2.08e-05	0.000489	CcSEcCtD
Azacitidine—Pruritus—Methylprednisolone—multiple sclerosis	2.08e-05	0.000489	CcSEcCtD
Azacitidine—Convulsion—Methotrexate—multiple sclerosis	2.06e-05	0.000485	CcSEcCtD
Azacitidine—Dyspepsia—Prednisone—multiple sclerosis	2.04e-05	0.000482	CcSEcCtD
Azacitidine—Arthralgia—Methotrexate—multiple sclerosis	2.03e-05	0.000477	CcSEcCtD
Azacitidine—Myalgia—Methotrexate—multiple sclerosis	2.03e-05	0.000477	CcSEcCtD
Azacitidine—Chest pain—Methotrexate—multiple sclerosis	2.03e-05	0.000477	CcSEcCtD
Azacitidine—Decreased appetite—Prednisone—multiple sclerosis	2.02e-05	0.000476	CcSEcCtD
Azacitidine—Rash—Prednisolone—multiple sclerosis	2.02e-05	0.000475	CcSEcCtD
Azacitidine—Dermatitis—Prednisolone—multiple sclerosis	2.01e-05	0.000474	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	2.01e-05	0.000474	CcSEcCtD
Azacitidine—Diarrhoea—Methylprednisolone—multiple sclerosis	2.01e-05	0.000473	CcSEcCtD
Azacitidine—Fatigue—Prednisone—multiple sclerosis	2e-05	0.000472	CcSEcCtD
Azacitidine—Headache—Prednisolone—multiple sclerosis	2e-05	0.000472	CcSEcCtD
Azacitidine—Discomfort—Methotrexate—multiple sclerosis	2e-05	0.000471	CcSEcCtD
Azacitidine—Constipation—Prednisone—multiple sclerosis	1.99e-05	0.000468	CcSEcCtD
Azacitidine—Confusional state—Methotrexate—multiple sclerosis	1.96e-05	0.000461	CcSEcCtD
Azacitidine—Dizziness—Triamcinolone—multiple sclerosis	1.94e-05	0.000458	CcSEcCtD
Azacitidine—Anaphylactic shock—Methotrexate—multiple sclerosis	1.94e-05	0.000457	CcSEcCtD
Azacitidine—Dizziness—Methylprednisolone—multiple sclerosis	1.94e-05	0.000457	CcSEcCtD
Azacitidine—Infection—Methotrexate—multiple sclerosis	1.93e-05	0.000454	CcSEcCtD
Azacitidine—Feeling abnormal—Prednisone—multiple sclerosis	1.91e-05	0.000451	CcSEcCtD
Azacitidine—Asthenia—Betamethasone—multiple sclerosis	1.91e-05	0.000451	CcSEcCtD
Azacitidine—Asthenia—Dexamethasone—multiple sclerosis	1.91e-05	0.000451	CcSEcCtD
Azacitidine—Nervous system disorder—Methotrexate—multiple sclerosis	1.9e-05	0.000448	CcSEcCtD
Azacitidine—Thrombocytopenia—Methotrexate—multiple sclerosis	1.9e-05	0.000448	CcSEcCtD
Azacitidine—Gastrointestinal pain—Prednisone—multiple sclerosis	1.9e-05	0.000447	CcSEcCtD
Azacitidine—Nausea—Prednisolone—multiple sclerosis	1.9e-05	0.000447	CcSEcCtD
Azacitidine—Pruritus—Dexamethasone—multiple sclerosis	1.89e-05	0.000444	CcSEcCtD
Azacitidine—Pruritus—Betamethasone—multiple sclerosis	1.89e-05	0.000444	CcSEcCtD
Azacitidine—Skin disorder—Methotrexate—multiple sclerosis	1.89e-05	0.000444	CcSEcCtD
Azacitidine—Hyperhidrosis—Methotrexate—multiple sclerosis	1.88e-05	0.000442	CcSEcCtD
Azacitidine—Vomiting—Triamcinolone—multiple sclerosis	1.87e-05	0.00044	CcSEcCtD
Azacitidine—Vomiting—Methylprednisolone—multiple sclerosis	1.87e-05	0.000439	CcSEcCtD
Azacitidine—Rash—Triamcinolone—multiple sclerosis	1.85e-05	0.000437	CcSEcCtD
Azacitidine—Dermatitis—Triamcinolone—multiple sclerosis	1.85e-05	0.000436	CcSEcCtD
Azacitidine—Anorexia—Methotrexate—multiple sclerosis	1.85e-05	0.000436	CcSEcCtD
Azacitidine—Rash—Methylprednisolone—multiple sclerosis	1.85e-05	0.000436	CcSEcCtD
Azacitidine—Dermatitis—Methylprednisolone—multiple sclerosis	1.85e-05	0.000435	CcSEcCtD
Azacitidine—Urticaria—Prednisone—multiple sclerosis	1.85e-05	0.000435	CcSEcCtD
Azacitidine—Headache—Triamcinolone—multiple sclerosis	1.84e-05	0.000434	CcSEcCtD
Azacitidine—Headache—Methylprednisolone—multiple sclerosis	1.84e-05	0.000433	CcSEcCtD
Azacitidine—Abdominal pain—Prednisone—multiple sclerosis	1.84e-05	0.000432	CcSEcCtD
Azacitidine—Body temperature increased—Prednisone—multiple sclerosis	1.84e-05	0.000432	CcSEcCtD
Azacitidine—Diarrhoea—Dexamethasone—multiple sclerosis	1.83e-05	0.00043	CcSEcCtD
Azacitidine—Diarrhoea—Betamethasone—multiple sclerosis	1.83e-05	0.00043	CcSEcCtD
Azacitidine—Hypotension—Methotrexate—multiple sclerosis	1.81e-05	0.000427	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.77e-05	0.000417	CcSEcCtD
Azacitidine—Dizziness—Dexamethasone—multiple sclerosis	1.76e-05	0.000415	CcSEcCtD
Azacitidine—Dizziness—Betamethasone—multiple sclerosis	1.76e-05	0.000415	CcSEcCtD
Azacitidine—Insomnia—Methotrexate—multiple sclerosis	1.76e-05	0.000414	CcSEcCtD
Azacitidine—Nausea—Triamcinolone—multiple sclerosis	1.75e-05	0.000411	CcSEcCtD
Azacitidine—Nausea—Methylprednisolone—multiple sclerosis	1.74e-05	0.00041	CcSEcCtD
Azacitidine—Dyspnoea—Methotrexate—multiple sclerosis	1.73e-05	0.000408	CcSEcCtD
Azacitidine—Hypersensitivity—Prednisone—multiple sclerosis	1.71e-05	0.000403	CcSEcCtD
Azacitidine—Dyspepsia—Methotrexate—multiple sclerosis	1.71e-05	0.000402	CcSEcCtD
Azacitidine—Vomiting—Dexamethasone—multiple sclerosis	1.7e-05	0.000399	CcSEcCtD
Azacitidine—Vomiting—Betamethasone—multiple sclerosis	1.7e-05	0.000399	CcSEcCtD
Azacitidine—Decreased appetite—Methotrexate—multiple sclerosis	1.69e-05	0.000397	CcSEcCtD
Azacitidine—Rash—Dexamethasone—multiple sclerosis	1.68e-05	0.000396	CcSEcCtD
Azacitidine—Rash—Betamethasone—multiple sclerosis	1.68e-05	0.000396	CcSEcCtD
Azacitidine—Dermatitis—Betamethasone—multiple sclerosis	1.68e-05	0.000396	CcSEcCtD
Azacitidine—Dermatitis—Dexamethasone—multiple sclerosis	1.68e-05	0.000396	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	1.68e-05	0.000395	CcSEcCtD
Azacitidine—Fatigue—Methotrexate—multiple sclerosis	1.67e-05	0.000394	CcSEcCtD
Azacitidine—Headache—Betamethasone—multiple sclerosis	1.67e-05	0.000394	CcSEcCtD
Azacitidine—Headache—Dexamethasone—multiple sclerosis	1.67e-05	0.000394	CcSEcCtD
Azacitidine—Asthenia—Prednisone—multiple sclerosis	1.67e-05	0.000392	CcSEcCtD
Azacitidine—Pain—Methotrexate—multiple sclerosis	1.66e-05	0.000391	CcSEcCtD
Azacitidine—Pruritus—Prednisone—multiple sclerosis	1.64e-05	0.000387	CcSEcCtD
Azacitidine—Feeling abnormal—Methotrexate—multiple sclerosis	1.6e-05	0.000377	CcSEcCtD
Azacitidine—Diarrhoea—Prednisone—multiple sclerosis	1.59e-05	0.000374	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methotrexate—multiple sclerosis	1.59e-05	0.000374	CcSEcCtD
Azacitidine—Nausea—Dexamethasone—multiple sclerosis	1.58e-05	0.000373	CcSEcCtD
Azacitidine—Nausea—Betamethasone—multiple sclerosis	1.58e-05	0.000373	CcSEcCtD
Azacitidine—Urticaria—Methotrexate—multiple sclerosis	1.54e-05	0.000363	CcSEcCtD
Azacitidine—Dizziness—Prednisone—multiple sclerosis	1.54e-05	0.000362	CcSEcCtD
Azacitidine—Abdominal pain—Methotrexate—multiple sclerosis	1.53e-05	0.000361	CcSEcCtD
Azacitidine—Body temperature increased—Methotrexate—multiple sclerosis	1.53e-05	0.000361	CcSEcCtD
Azacitidine—Vomiting—Prednisone—multiple sclerosis	1.48e-05	0.000348	CcSEcCtD
Azacitidine—Rash—Prednisone—multiple sclerosis	1.46e-05	0.000345	CcSEcCtD
Azacitidine—Dermatitis—Prednisone—multiple sclerosis	1.46e-05	0.000345	CcSEcCtD
Azacitidine—Headache—Prednisone—multiple sclerosis	1.46e-05	0.000343	CcSEcCtD
Azacitidine—Hypersensitivity—Methotrexate—multiple sclerosis	1.43e-05	0.000337	CcSEcCtD
Azacitidine—Asthenia—Methotrexate—multiple sclerosis	1.39e-05	0.000328	CcSEcCtD
Azacitidine—Nausea—Prednisone—multiple sclerosis	1.38e-05	0.000325	CcSEcCtD
Azacitidine—Pruritus—Methotrexate—multiple sclerosis	1.37e-05	0.000323	CcSEcCtD
Azacitidine—Diarrhoea—Methotrexate—multiple sclerosis	1.33e-05	0.000313	CcSEcCtD
Azacitidine—Dizziness—Methotrexate—multiple sclerosis	1.28e-05	0.000302	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—ZNF746—multiple sclerosis	1.27e-05	0.0235	CbGpPWpGaD
Azacitidine—Vomiting—Methotrexate—multiple sclerosis	1.23e-05	0.000291	CcSEcCtD
Azacitidine—Rash—Methotrexate—multiple sclerosis	1.22e-05	0.000288	CcSEcCtD
Azacitidine—Dermatitis—Methotrexate—multiple sclerosis	1.22e-05	0.000288	CcSEcCtD
Azacitidine—Headache—Methotrexate—multiple sclerosis	1.22e-05	0.000286	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—PTBP1—multiple sclerosis	1.16e-05	0.0215	CbGpPWpGaD
Azacitidine—Nausea—Methotrexate—multiple sclerosis	1.15e-05	0.000272	CcSEcCtD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—multiple sclerosis	1.08e-05	0.02	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—U2AF2—multiple sclerosis	8.8e-06	0.0163	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—HNRNPA1—multiple sclerosis	8.8e-06	0.0163	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SRM—multiple sclerosis	8.66e-06	0.016	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ZNF746—multiple sclerosis	8.57e-06	0.0159	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PTBP1—multiple sclerosis	7.84e-06	0.0145	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ZFP36L1—multiple sclerosis	6.96e-06	0.0129	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP27B1—multiple sclerosis	6.1e-06	0.0113	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP24A1—multiple sclerosis	6.1e-06	0.0113	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—HNRNPA1—multiple sclerosis	5.94e-06	0.011	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—U2AF2—multiple sclerosis	5.94e-06	0.011	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	5.64e-06	0.0104	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GPC5—multiple sclerosis	5.58e-06	0.0103	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PABPC1—multiple sclerosis	5.39e-06	0.00998	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—RPL5—multiple sclerosis	4.86e-06	0.009	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ZFP36L1—multiple sclerosis	4.7e-06	0.00869	CbGpPWpGaD
Azacitidine—CDA—Metabolism—RRM1—multiple sclerosis	4.62e-06	0.00855	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PGR—multiple sclerosis	3.83e-06	0.00709	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PABPC1—multiple sclerosis	3.64e-06	0.00674	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—RPL5—multiple sclerosis	3.29e-06	0.00608	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—VDR—multiple sclerosis	2.68e-06	0.00495	CbGpPWpGaD
Azacitidine—CDA—Metabolism—BCHE—multiple sclerosis	2.65e-06	0.00491	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PGR—multiple sclerosis	2.59e-06	0.00479	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—VDR—multiple sclerosis	1.81e-06	0.00335	CbGpPWpGaD
Azacitidine—CDA—Metabolism—APOE—multiple sclerosis	1.6e-06	0.00295	CbGpPWpGaD
Azacitidine—CDA—Metabolism—POMC—multiple sclerosis	1.37e-06	0.00254	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ALB—multiple sclerosis	1.25e-06	0.00231	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—MYC—multiple sclerosis	1.06e-06	0.00197	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—MYC—multiple sclerosis	7.19e-07	0.00133	CbGpPWpGaD
